Cancer Institute A national cancer institute
designated cancer center

Neyssa Marina

Publication Details

  • A phase I study of ifosfamide with Mesna given daily for 3 consecutive days to children with malignant solid tumors.

    Pratt CB, Meyer WH, Douglass EC, Bowman L, Wilimas J, Ochs J, Marina N, Avery L, Thompson EI. Cancer. 1993; 71 (11): 3661-5

    The authors conducted a Phase I dose escalation trial of ifosfamide given daily for 3 consecutive days to 29 children with malignant solid tumors. Twenty-eight of these children had received prior chemotherapy.

    PubMedID: 8490914

Stanford Medicine Resources:

Footer Links: